VEGF in brain tumors

Journal of Neuro-Oncology

Volumn 50, Issue 1-2, 2000, Pages 109-120

  Machein, M R ^a   Plate, K H ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Angiogenesis; Brain edema; Brain tumors; VEGF; VEGF receptors

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; BIOCHEMISTRY; BLOOD VESSEL PERMEABILITY; BRAIN EDEMA; BRAIN TUMOR; CARCINOGENESIS; DRUG TARGETING; HORMONE INHIBITION; HUMAN; MOLECULAR BIOLOGY; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW;

ANGIOGENESIS INHIBITORS; ANIMALS; BRAIN EDEMA; BRAIN NEOPLASMS; CAPILLARY LEAK SYNDROME; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HEMANGIOBLASTOMA; HUMANS; LYMPHOKINES; MENINGEAL NEOPLASMS; MENINGIOMA; MICE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN ISOFORMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034470387     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006416003964     Document Type: Review

References (130)

1. What is the evidence that tumors are angiogenesis-dependent?
2. Tumor angiogenesis
3. Vasculogenesis, angiogenesis and endothelial cell differentiation during embryonic development
4. What, if anything, is an angiogenic factor?
5. Matrix metalloproteases in angiogenesis: A moving target for therapeutic intervention
6. Patterns and emerging mechanisms of angiogenic switch during tumorigenesis
7. Regulators of angiogenesis
8. Vascular endothelial growth factor and its receptors
9. Tumor secrets a vascular permeability factor that promotes accumulation of ascistes fluid
10. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculostellate cells
11. Vascular endothelial growth factor is a secreted angiogenic mitogen
12. Vascular endothelial growth factor, an endothelial cell mitogen related to PDGF
13. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
14. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
15. Vascular permeability factor (VPF, VEGF) in tumor biology
16. +2 and von Willebrand factor release in human endothelial cells
17. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries
18. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
19. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
20. The vascular endothelial growth factor family of polypeptides
21. Vascular endothelial growth factor expression, vascular volume, and capillary permeability in human brain tumors
22. Intracerebral tumor-associated hemorrhage caused by overexpression of vascular endothelial growth factor proforms VEGF121 and VEGF165 but not VEGF189
23. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to fms family
24. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
25. Identification of the KDR tyrosine kinase receptor as a receptor for vascular endothelial growth factor
26. High affinity VEGF binding and development expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis
27. Coordinate expression of VEGF-receptor 1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development
28. Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor
29. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
30. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoetic cells and exhibiting close genetic linkage to c-kit
31. Failure of blood-island formation and vasculogenesis in flk-1-deficient mice
32. Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
33. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
34. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
35. Isolation of human placental cDNA coding for a protein related to the vascular permeability factor
36. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
37. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
38. Cloning and characterization of a novel human gene related to vascular endothelial growth factor
39. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D
40. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases
41. VEG-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
42. Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells
43. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells
44. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology
45. Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF, PDGF-BB and bFGF
46. Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells
47. Interleukin 6 induces the expression of vascular endothelial growth factor
48. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus rapid stimulation by estrogen correlates with estrogen-induced increases in uterine permeability and growth
49. Mutatant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression
50. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel Lindau tumor suppressor protein
51. Mutant ras oncogene upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
52. Both v-Ha Ras and v-Raf stimulate expression of vascular endothelial growth factor in NIH 3T3 cells
53. Wild-type p53 and v-src exert opposing influences on human vascular endothelial growth factor gene expression
54. The human gene for vascular endothelial growth factor
55. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia initiated angiogenesis
56. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells
57. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms
58. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor-1
59. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
60. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
61. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas
62. Genes for epidermal growth factor receptor, transforming growth factor and epidermal growth factor and their expression in humans gliomas in vivo
63. Platelet-derived growth factor receptor-β is induced during tumor progression in endothelial cells in human gliomas
64. Platelet-derived growth factor and its receptor in human glioma tissue: Expression of messanger RNA and protein suggests the presence of autocrine and paracrine loops
65. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
66. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasm
67. Expression and distribution of vascular endothelial growth factor protein in human brain tumors
68. Expression of vascular endothelial growth factor in human brain tumors
69. Vascular permeability factor in brain metastasis: Correlation with vasogenic brain edema and tumor angiogenesis
70. Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma
71. Epidermiology of brain tumors
72. Tumor angiogenesis: A quantitative method for histologic grading
73. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptor, distribution of VEGF protein and possible in vivo regulatory mechanisms
74. Hypoxia-mediated selection of cells with diminished apopotic potential in solid tumors
75. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression
76. Upregulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumour angiogenesis
77. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors
78. Upregulation of flk-1/VEGF receptor-2 by its ligand in a cerebral slice culture system
79. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro
80. Expression of vascular endothelial growth factor and its possible relation with neovascularization human brain tumors
81. Vascular endothelial growth/permeability factor expression in human glioma specimens: Correlation with vasogenic brain edema and tumor-associated cysts
82. Expression of vascular endothelial growth factor and its receptors in pilocytic astrocytoma
83. Molecular neuropathology of astrcytic tumors
84. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma
85. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas
86. Cerebellar capillary hemangioblastomas: Its histogenesis studied by organ culture and electron microscopy
87. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas
88. Expression of vascular endothelial growth factor in capillary hemangioblastoma
89. Expression of growth factors and growth factor receptors in capillary hemangioblastomas
90. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function
91. Somatic mutations of von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas
92. Mutation of von Hippel-Lindau tumor suppressor gene in capillary hemangioblastomas of the central nervous system
93. Binding of the von Hippel-Lindau tumor suppressor gene to Elongin B and C
94. Inhibition of transcription by VHL tumor suppressor protein
95. Negative regulation of hypoxia-inducible genes by von Hippel-Lindau protein
96. Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of transcription factor HRF/HIF-2 alpha
97. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 in microcystic meningiomas
98. Meningiomas: Role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema
99. Meningiomas
100. The biology of meningiomas
101. Characterization of epidermal growth factor receptor in human meningiomas
102. Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their products
103. Constitutive co-expression of estrogen and progesterone receptor mRNA in human meningiomas by RT-PCR and response of in vitro cell cultures to steroid hormones
104. Expression of androgen and progesterone receptors in primary human meningiomas
105. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis
106. Expression and localization of placenta growth factor and PIGF receptors in human meningiomas
107. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid
108. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 regulation by serum, growth factors, oncoproteins and hypoxia
109. Electron microscopy of the blood-brain barrier in disease
110. Vascular permeability factor: A unique regulator of blood vessel function
111. The genesis of peritumoral vasogenic brain edema and tumor cysts, a hypothetical role for tumor-derived vascular permeability factor
112. Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic edema in meningiomas
113. Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression
114. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor
115. Neovasculature induced by vascular endothelial growth factor is fenestrated
116. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues
117. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
118. Mechanism of dexamethasone suppression of brain tumor associated vascular permeability in rats
119. Differential down-regulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells
120. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
121. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence
122. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
123. Dominant-negative inhibition of flk-1 suppresses the growth of many tumors in vivo
124. Anti-angiogenic gene therapy in rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2
125. Inhibition of tumor growth by targeting endothelium using a soluble vascular endothelial growth factor receptor
126. Flk-1 as a target for tumor growth inhibition
127. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of flt-1 vascular endothelial growth factor receptor
128. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis and mortality rate